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Abstract
We previously reported that human immunodeficiency virus type 2 (HIV-2) carrying alanine or glutamine but not proline at
position 120 of the capsid protein (CA) could grow in the presence of anti-viral factor TRIM5a of cynomolgus monkey (CM).
To elucidate details of the interaction between the CA and TRIM5a, we generated mutant HIV-2 viruses, each carrying one
of the remaining 17 possible amino acid residues, and examined their sensitivity to CM TRIM5a-mediated restriction. Results
showed that hydrophobic residues or those with ring structures were associated with sensitivity, while those with small side
chains or amide groups conferred resistance. Molecular dynamics simulation study revealed a structural basis for the
differential TRIM5a sensitivities. The mutations at position 120 in the loop between helices 6 and 7 (L6/7) affected
conformation of the neighboring loop between helices 4 and 5 (L4/5), and sensitive viruses had a common L4/5
conformation. In addition, the common L4/5 structures of the sensitive viruses were associated with a decreased probability
of hydrogen bond formation between the 97th aspartic acid in L4/5 and the 119th arginine in L6/7. When we introduced
aspartic acid-to-alanine substitution at position 97 (D97A) of the resistant virus carrying glutamine at position 120 to disrupt
hydrogen bond formation, the resultant virus became moderately sensitive. Interestingly, the virus carrying glutamic acid at
position 120 showed resistance, while its predicted L4/5 conformation was similar to those of sensitive viruses. The D97A
substitution failed to alter the resistance of this particular virus, indicating that the 120th amino acid residue itself is also
involved in sensitivity regardless of the L4/5 conformation. These results suggested that a hydrogen bond between the L4/5
and L6/7 modulates the overall structure of the exposed surface of the CA, but the amino acid residue at position 120 is also
directly involved in CM TRIM5a recognition.
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Introduction
Human immunodeficiency virus type 1 (HIV-1) infects humans
and chimpanzees but not Old World Monkeys (OWM) such as
Rhesus monkey (Rh) and cynomolgus monkey (CM). This is
attributedto a barrier in the host cell. In 2004,the screening of a Rh
cDNA library identified TRIM5a as one of cellular antiviral factors
[1]. TRIM5 is a member of the tripartite motif family containing
RING, B-box and coiled-coil domains [2]. The alpha isoform of
TRIM5 has an additional C-terminal PRYSPRY (B30.2) domain.
Several studies have shown that sequence variation in variable
regions of the PRYSPRY domain among different monkey species
affects species-specific retrovirus infection [3–11].
Rh and CM TRIM5as restrict HIV-1 but not simian
immunodeficiency virus isolated from macaque (SIVmac) [1,5],
whereas African green monkey (AGM) TRIM5a inhibits both
HIV-1 and SIVmac [5,12]. Human TRIM5a only weakly restricts
HIV-1, but potently restricts N-tropic murine leukemia virus (N-
MLV) [11,12].
Details of the molecular mechanism of retrovirus restriction by
TRIM5a have been gradually elucidated by several groups.
TRIM5a associates with the N-MLV capsid in detergent-stripped
virions [13] or with an artificially constituted core structure
composed of an HIV-1 capsid-nucleocapsid (CA-NC) fusion
protein in a PRYSPRY domain-dependent manner [14], indicat-
ing that the target of TRIM5a is multimerized capsids. In
addition, it was demonstrated that engagement of a restriction-
sensitive retroviral core results in TRIM5a degradation by a
proteasome-dependent pathway [15]. In the presence of protea-
some inhibitors, virions complete reverse transcription and form
functional pre-integration complexes, but 2-long terminal repeat
circle formation and gene expression remain impaired [16,17].
Recently, we have reported that AGM TRIM5a restricted
SIVmac mainly via the proteasome-dependent pathway, whereas
HIV-1 and HIV-2 restriction by AGM TRIM5a was both
proteasome-dependent and proteasome-independent [18].
HIV-2 and SIVmac have very similar genomes [19], but vary in
their ability to grow in the presence of TRIM5a from various
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e22779Figure 1. Growth of GH123 and its mutant viruses in the presence of CM TRIM5a. MT4 cells were infected with CM-TRIM5a-SeV (black
circles) or CM-SPRY(–)-SeV (white circles) then superinfected with GH123 mutant viruses. Culture supernatants were periodically assayed for levels of
virus capsid. Error bars show actual fluctuations between measurements of capsid in duplicate samples. A representative of two independent
experiments is shown.
doi:10.1371/journal.pone.0022779.g001
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whereas HIV-2 strains GH123 and ROD are sensitive to these
TRIM5as [5,8,20,21]. We previously investigated the growth of
eight different HIV-2 isolates in the presence of CM and human
TRIM5as and demonstrated that the growth of HIV-2 isolates
carrying proline (P) at the 119th or 120th position of the capsid
protein (CA) was inhibited by CM and human TRIM5as, whereas
the growth of those with either alanine (A) or glutamine (Q) was
not affected by these TRIM5as [20]. In a Caio cohort study in
west Africa, it was demonstrated that subjects with a lower viral
load more frequently carried a P at the 119th position of the CA,
which corresponds to the 120th position of the GH123 CA, while
non-proline residues at this position were more frequently
observed in subjects with a high viral load [22], suggesting that
TRIM5a controls viral replication in HIV-2-infected individuals.
The 120th amino acid is located in the loop between helices 6
and 7 (L6/7) [20]. Recently, we have succeeded in improving the
replication of simian-tropic HIV-1 in CM cells by introducing the
SIVmac L6/7 CA sequence [23]. In the present study, we
generated mutant HIV-2 viruses each carrying one of the
remaining 17 possible amino acid residues at the 120th position,
and examined their susceptibilities to TRIM5a-mediated restric-
tion in order to elucidate details of the interaction between HIV-2
CA and TRIM5a. Computer-assisted structural study showed that
the mutations at position 120 in L6/7 affected conformation of the
neighboring loop between helices 4 and 5 (L4/5).
Results
Amino acid residues at the 120th position of HIV-2
GH123 CA and viral susceptibility to CM TRIM5a
In a previous study, we reported that HIV-2 isolates carrying P
at the 120th position of the CA were sensitive to CM and human
TRIM5as, whereas those with either A or Q were not [20]. In the
Los Alamos sequence database, the amino acid residue at the
119th or 120th position of almost all HIV-2 CAs is P, A, Q or
glycine (G). Therefore, we first generated mutant HIV-2 GH123
viruses carrying G at the 120th position (GH123/G) to investigate
its effect on TRIM5a susceptibility.
Equal amounts of p25 of mutant and wild type viruses were
inoculated into the human T cell line MT4 expressing CM
TRIM5a, and culture supernatants were periodically assayed for
CA production. In agreement with the results of the previous
study, wild type GH123 carrying P at the 120th position (GH123/
P) was sensitive to CM TRIM5a since this virus failed to grow in
the presence of CM TRIM5a. On the other hand, GH123/G as
well as GH123/Q (glutamine) and GH123/A (alanine) were
Figure 2. Western blot analysis of the CA in particles of GH123
and its mutant viruses. The viral particles of GH123 wild type and its
mutant viruses were purified by ultracentrifugation through a 20%
sucrose cushion. p25 capsid protein was visualized by western blotting
(WB) using SIV-infected monkey serum.
doi:10.1371/journal.pone.0022779.g002
Figure 3. Growth of SIVmac239 and its mutant viruses in the presence of CM TRIM5a. MT4 cells were infected with CM-TRIM5a-SeV (black
circles) or CM-SPRY(–)-SeV (white circles) then superinfected with SIVmac239 mutant viruses. Culture supernatants were periodically assayed for levels
of virus capsid. Error bars show actual fluctuations between measurements of capsid in duplicate samples. A representative of three independent
experiments is shown.
doi:10.1371/journal.pone.0022779.g003
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presence of CM TRIM5a (Figure 1A).
To determine whether amino acid residues other than P, Q, A
and G can occupy the 120th position of HIV-2 GH123 CA, and to
elucidate further details of the interaction between the CA and
TRIM5a, we generated 16 mutant GH123 viruses each carrying
one of the remaining possible amino acid residues at the 120th
position. As shown in Figure 1B, viruses with amino acid residues
bearing a ring structure including aromatic groups, namely,
histidine (GH123/H), phenylalanine (GH123/F), tyrosine
(GH123/Y), tryptophan (GH123/W) and GH123/P were all
sensitive to CM TRIM5a. Hydrophobic valine (GH123/V),
leucine (GH123/L), and isoleucine (GH123/I) viruses as well as
sulfated methionine (GH123/M) and cysteine (GH123/C) viruses
were also sensitive.
In contrast, viruses with amino acid residues bearing hydroxyl
or amide groups, namely, serine (GH123/S), threonine (GH123/
T), glutamine (GH123/Q) and asparagine (GH123/N) were
resistant to CM TRIM5a. Acidic aspartic acid (GH123/D) and
glutamic acid (GH123/E) viruses were also resistant, although
they grew to slightly lower titers than wild type GH123/P in the
absence of CM TRIM5a. The replication of viruses with basic
arginine (GH123/R) and lysine (GH123/K) was severely impaired
and it was impossible to evaluate the effects of these residues on
susceptibility to TRIM5a. Almost identical results were obtained
when we inoculated equal amounts of reverse transcriptase of
mutant and wild type GH123 (data not shown). Thus, the nature
of the 120th amino acid residue greatly affects viral sensitivity to
CM TRIM5a.
CA processing is not affected by the 120th mutation
To understand why GH123/R and GH123/K failed to
replicate even in the absence of TRIM5a, we examined the Gag
processing of mutant and wild type HIV-2 GH123 viruses using
western blot analysis of viral particles. As shown in Figure 2, all
mutant HIV-2 GH123 viruses produced viral particles with
processed Gag proteins similar to the wild type virus. These results
clearly exclude the possibility that the impaired replication of
GH123/K and GH123/R viruses were due to inefficient
processing of Gag precursors.
The 118th position of SIVmac239 CA and viral
susceptibility to CM TRIM5a
HIV-2, simian immunodeficiency virus isolated from sooty
mangabey (SIVsm), and SIVmac have similar genomes [19].
SIVmac239 can replicate in the presence of CM TRIM5a [5] and
Figure 4. Structural models of the HIV-2 capsid N-terminal domain. Models were constructed by homology modeling and molecular
dynamics simulations with the high-resolution X-ray crystal structure of the HIV-2 capsid N-terminal domain (PDB code: 2WLV [29]) as the starting
structure. Averaged conformations of the overall structure of the N-terminal domain during 5–20 nanoseconds of MD simulations (A and B) and a
close-up view around the L4/5 loop (C and D) are indicated. N and C indicate the amino termini and carboxyl termini, respectively; and the seven
color-coded a-helices are labeled. Red and blue cartoons indicate the N-terminal loop, L4/5, and L6/7 of CM TRIM5a-sensitive (GH123/P, GH123/F,
GH123/H and GH123/I) and CM TRIM5a-resistant (GH123/Q, GH123/A and GH123/N) viruses, respectively. Gray cartoons indicate the N-terminal loop,
L4/5 and L6/7 of GH123/E in which the structures and biologic phenotypes are inconsistent. Models from two different angles are shown.
doi:10.1371/journal.pone.0022779.g004
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position of the GH123 CA. In our previous study, we reported that
mutant SIVmac239 carrying P at the 118th position (SIVmac239/
P) became sensitive to CM and human TRIM5as [20]. In the
present study, we examined whether other amino acid residues
that conferred resistance (A, G) or sensitivity (valine, V) to CM
TRIM5a or abolished viral replicative ability (arginine, R) on a
GH123 background showed similar effects on viral sensitivity to
CM TRIM5a on an SIVmac239 background.
As shown in Figure 3, CM TRIM5a did not affect the
replication of wild type SIVmac239 but inhibited SIVmac239/P,
which is in agreement with the results of the previous study [20]. It
should be noted, however, that the inhibitory effect of CM
TRIM5a on SIVmac239/P was smaller than that on GH123/P,
since SIVmac239/P demonstrated some growth even in the
presence of CM TRIM5a. Newly generated SIVmac239 carrying
alanine (SIVmac239/A) or glycine (SIVmac239/G) at the 118th
position were unaffected by CM TRIM5a (Figure 3).
On the other hand, the mutant SIVmac239 carrying valine
(SIVmac239/V) was only weakly inhibited by CM TRIM5a
(Figure 3) to a lesser degree than the GH123/V. As shown in
Figure 1, the inhibitory effect on GH123/V was also smaller than
that on GH123/P even on a GH123 background. These results
clearly indicate that single amino acid substitutions at the 118th
position of the SIVmac239 CA had similar effects to those at the
120th position of GH123, although their impact was smaller in
SIVmac239 than in the GH123 CA. Nevertheless, replication of
mutant SIVmac239 carrying arginine (SIVmac239/R) was
severely impaired, as with GH123/R.
Molecular modeling and molecular dynamics (MD)
simulations of the HIV-2 capsid N-terminal domain
The amino acid at position 120 is located in the L6/7 of the N-
terminal domain of the CA. To obtain structural insights into the
mechanisms by which this amino acid controls viral sensitivity to
TRIM5a-mediated restriction, we conducted computer-assisted
structural study of the N-terminal domain of the CA. With
homology modeling and molecular dynamics (MD) simulation
techniques, we constructed a series of initial structural models of
the N-terminal half of the CA from CM TRIM5a-sensitive
(GH123/P, GH123/F, GH123/H, and GH123/I) and CM
TRIM5a-resistant (GH123/Q, GH123/A, GH123/N, and
GH123/E) viruses. The initial models were then subjected to
the MD simulation to analyze structural dynamics of the N-
terminal domain of the CA in water environment. Average
structures of individual CA mutants were obtained with 60,000
trajectories during 5–20 nanoseconds of MD simulations.
Comparisons of the average structures revealed that amino acid
substitutions at position 120 could significantly influence the
overall conformation of the exposed surface of the HIV-2 CA
(Figure 4). Notably, the L4/5 of the mutant CAs are classified into
two subgroups on the basis of their conformational similarities.
These subgroups are primarily coincident with the two phenotypic
subgroups based on viral sensitivities to CM TRIM5a, with the
exception of mutant GH123/E (Figure 4, cartoon models
indicated by gray). TRIM5a-sensitive viruses GH123/P,
GH123/F, GH123/H and GH123/I showed almost identical
L4/5 conformation (Figure 4, red models), while L4/5 of
TRIM5a-resistant viruses GH123/Q, GH123/A and GH123/N
were more variable (Figure 4, blue models). To confirm this, we
performed additional modeling of TRIM5a-resistant viruses
GH123/T and GH123/S. The results showed that L4/5 of
GH123/T and GH123/S were also variable (data not shown).
Furthermore, the MD simulation study revealed that the
common L4/5 structures of the TRIM5a-sensitive viruses were
associated with a reduced probability of hydrogen bond formation
between the 97th aspartic acid (D) in L4/5 and the 119th arginine
(R) in L6/7 compared with those of TRIM5a-resistant viruses
except for GH123/E (Figure 5A and Table 1). We, therefore,
hypothesized that the presence of the hydrogen bond between the
97th D in L4/5 and the 119th R in L6/7 disrupted the L4/5
conformation required for recognition by TRIM5a. To examine
whether hydrogen bond formation between the 97th D and 119th
R indeed affects the viral sensitivity to CM TRIM5a-mediated
restriction, we introduced an alanine substitution at the 97th
Figure 5. Hydrogen bond formation among L4/5, L6/7 and
helix 6 of the HIV-2 CA. Close-up views of averaged structures of the
N-terminal domain of the GH123/P CA during 5–20 nanoseconds of MD
simulations are shown. Red, blue, purple, orange and green wireframes
denote side chains of arginine at the 96th (96R), aspartic acid at the
97th (97D), glutamic acid at the 112th (112E), tryptophan at the 116th
(116W) and arginine at the 119th (119R) positions, respectively. Dotted
lines indicate hydrogen bonds visualized with MOE 2009. Models from
two different angles are shown.
doi:10.1371/journal.pone.0022779.g005
HIV-2 Capsid Structure and TRIM5a Sensitivity
PLoS ONE | www.plosone.org 5 July 2011 | Volume 6 | Issue 7 | e22779position of the TRIM5a-resistant viruses GH123/Q (D97A-
GH123/Q) and GH123/A (D97A-GH123/A). The side chain of
A at the 97th position would be too small to form a hydrogen bond
with the 119th R, which was confirmed by MD simulation study of
the D97A CA mutant of GH123/Q (Figure 6). As expected, the
D97A substitution conferred moderate sensitivity to CM TRIM5a
upon the resistant viruses GH123/Q and GH123/A (Figure 7A
and 7B). In the case of TRIM5a-sensitive virus GH123/P, in
which the probability of hydrogen bond formation between the
97th D and 119th R was predicted to be low (Table 1), the D97A
substitution did not alter the viral senstivity to CM TRIM5a
(Figure 7C). These data suggest that the conformation of L4/5,
which is influenced by that of L6/7, participates in determining
viral sensitivities to CM TRIM5a-mediated restriction. It should
be noted, however, that the D97A substitution slightly impaired
the replication of GH123/Q and GH123/A, as indicated by the
titers of D97A-GH123/Q and D97A-GH123/A, which were
apparently lower than those of GH123/Q and GH123/A at day 5
after infection even in the absence of TRIM5a (Figure 7A and 7B).
Although we further tried to disrupt the hydrogen bond formation
by introducing an alanine substitution at the 119th position, the
resultant mutant viruses did not grow (data not shown). The
arginine at the 119th position is highly conserved among different
HIV-2 strains and may be essential for virus replication.
In the case of the TRIM5a-resistant virus GH123/E (Figure 4,
gray model), however, the conformation of L4/5 was similar to
those of CM TRIM5a-sensitive viruses GH123/P, GH123/F,
GH123/H and GH123/I (Figure 4, red models). The probability
of hydrogen bond formation was also low in GH123/E, unlike
that in the other resistant viruses GH123/Q, GH123/A and
GH123/N (Table 1). Because GH123/E has a negatively
charged amino acid E at the 120th position, we performed
additional modeling of the CM TRIM5a-resistant virus with
another negatively charged amino acid D (GH123/D). The
results showed that the conformation of GH123/D L4/5 was also
similar to those of CM TRIM5a-sensitive viruses (data not
shown). Consistent with this, the possibility of hydrogen bond
formation was low (21.27%) in GH123/D just as in GH123/E. It
Figure 6. Lack of hydrogen bond formation between the 97th alanine and the 119th arginine of HIV-2 D97A-GH123/Q CA. Close-up
views of averaged structures around the L4/5 loop of GH123/Q (left) and D97A-GH123/Q (right) during 5–20 nanoseconds of MD simulations are
shown. Red, blue and green wireframes denote side chains of aspartic acid at the 97th (97D), arginine at the 119th (119R), and alanine at the 97th
(97A) positions, respectively. A dotted line indicates a hydrogen bond.
doi:10.1371/journal.pone.0022779.g006
Table 1. The probability of forming a hydrogen bond between the 97th aspartic acid in L4/5 and the 119th arginine in L6/7 of the
CA in 60,000 trajectories during 5–20 nanoseconds of MD simulations and the sensitivity phenotype.
120th amino acid Frequency of hydrogen bond (%) Sensitivity to CM TRIM5a
Pro (P) 44.6 Sensitive
Phe (F) 41.5 Sensitive
His (H) 42.99 Sensitive
Ile (I) 0 Sensitive
Ala (A) 64.47 Resistant
Gln (Q) 55.15 Resistant
Asn (N) 55.7 Resistant
Glu (E) 21.27 Resistant
Ser (S) 63.51 Resistant
Thr (T) 51.48 Resistant
doi:10.1371/journal.pone.0022779.t001
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position prevented access of TRIM5a even though the L4/5
conformation was adequate for TRIM5a recognition. If our
modeling of GH123/E L4/5 was correct, disruption of the
hydrogen bond between the 97th D and 119th R would have
little or no effect on the TRIM5a sensitivity of GH123/E. In fact,
the D97A substitution failed to alter the resistant phenotype of
GH123/E (Figure 7D), but did unexpectedly compensate the
impaired replication of GH123/E (Figure 1B). These results
indicate that the effect of D97A substitution depended upon the
amino acid residue at the 120th position, and further supported
the notion that the L6/7 itself was also involved in CM TRIM5a
restriction. Consistent with this, the side chains of amino acid
residues at the 120th position were exposed on the surface of the
CA (Figure 8).
When these results are considered together, it is likely that the
hydrogen bond between the L4/5 and L6/7 modulates the overall
structure of the exposed surface of the CA and that both L4/5 and
L6/7 are responsible for CA recognition by CM TRIM5a.
Discussion
In the present study, we showed that a hydrogen bond between
the 97th D and the 119th R of HIV-2 CA affected viral sensitivity
to CM TRIM5a. TRIM5a-sensitive viruses showed a common
L4/5 structure, but L6/7 was also important in CA recognition by
TRIM5a.
Previously, we proposed that the configuration of HIV-2 CA
L6/7 would affect viral sensitivity to CM TRIM5a on the basis of
the results of homology modeling of the HIV-2 CA in which the 3-
D structure of HIV-1 CA was used as a template [20]. In the
present study, however, we performed intensive mutational
analysis of the HIV-2 CA followed by more intensive computer-
assisted structural analyses using the recently published 3-D
structure of the HIV-2 CA and MD simulation, which provide
information on structural dynamics of proteins in solution. Results
of the present study revealed that alterations in the L4/5
conformation were more strongly associated with viral sensitivity
to TRIM5a than those in the L6/7 configuration. Furthermore,
the data on the MD simulation study disclosed that a hydrogen
bond between the 97th D and the 119th R may be a critical
modulator affecting the conformation of L4/5.
In the case of the HIV-1 CA, two hydrogen bonds were
reported to form between R at the 229th position of Gag (R229)
and E at the 245th position (E245), and between R229 and W at
the 249th position (W249) [24]. These three amino acids were also
found in the HIV-2 CA; and R229, E245 and W249 of the HIV-1
CA correspond to the 96th R, 112th E and the 116th W of the
HIV-2 GH123 CA, respectively (Fig. 5B). The 112th E and 116th
W are in the 6th helix of the CA, and the 96th R is adjacent to the
97th D in L4/5. In our HIV-2 CA models, these two hydrogen
bonds were observed with a probability of more than 99.9%,
regardless of the viral sensitivity to TRIM5a. Therefore,
TRIM5a-resistant viruses are likely to have three hydrogen bonds
at the base of L4/5, whereas those sensitive to TRIM5a have two
hydrogen bonds there. It is possible that reduced structural
flexibility of the base of loop causes the upper loop structure to
collapse more easily. Thus, the number of the hydrogen bonds
may affect the flexibility of the base of L4/5 and the maintenance
of the binding surface for TRIM5a, which is formed at least partly
by L4/5. As a result, the viral sensitivity to TRIM5a changes.
In the CA sequences of HIV-2 and SIVmac in the Los Alamos
Database, the 97th position was always occupied by acidic D or E,
and the 119th position was always occupied by R. In the case of
HIV-1 or simian immunodeficiency virus isolated from the
chimpanzee (SIVcpz), however, the 119th position was occupied
by variable amino acid residues, while the 97th position was
always occupied by acidic D or E. It should be noted that a
hydrogen bond between the 97th and 119th amino acid residues
was never observed in the HIV-1 CA (data not shown). Those
differences may contribute to the increased sensitivity of HIV-1 to
OWM TRIM5a compared with HIV-2 strains.
Although our data showed a clear correlation between viral
sensitivity to TRIM5a and the conformation of CA L4/5, there
was one exception. The conformation of L4/5 in GH123/E was
Figure 7. Effects of an aspartic acid-to-alanine substitution at
the 97th position of the HIV-2 CA on viral growth in the
presence or absence of CM TRIM5a. MT4 cells were infected with
CM-TRIM5a-SeV (black circles) or CM-SPRY(–)-SeV (white circles) then
superinfected with GH123 mutant viruses. Culture supernatants were
periodically assayed for levels of viral capsid. Error bars show actual
fluctuations between measurements of capsid in duplicate samples. A
representative of three independent experiments is shown.
doi:10.1371/journal.pone.0022779.g007
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GH123/E was highly resistant to CM TRIM5a.F u r t h e r m o r e ,
disruption of the hydrogen bond between the 97th D and the
119th R by substitution of D97A did not alter the resistant
phenotype of GH123/E at all. These results suggested that the
120th amino acid residue of the HIV-2 GH123 CA itself is also
involved in CM TRIM5a sensitivity independently from the
L4/5 conformation. This view was also supported by our
present observation that disruption of the hydrogen bond
between the 97th D and the 119th R conferred only moderate
sensitivity to CM TRIM5a upon another resistant virus
GH123/Q (Figure 7).
Replication of GH123/E or GH123/D was slightly impaired
(Figure 1B), but this impairment was compensated by the D97A
substitution in GH123/E (Figure 7D). On the other hand,
replication of GH123/Q was almost comparable to that of
GH123 (Figure 1A); but the D97A substitution slightly impaired its
replicative capability (Figure 7A). It should be also mentioned here
that the viruses with basic residues at the 120th position, GH123/
R and GH123/K, scarcely grew (Figure 1B). These results suggest
that certain optimum levels of charge are required at the L4/5 and
L6/7 for efficient viral replication. At present, it is unclear why
those charge differences affect the growth capability of the virus;
but it is possible that the charge difference affects the accessibility
to unknown host factor(s) involved in uncoating.
HIV-2 closely resembles SIVsm, which is thought to have
entered the human population on at least eight separate occasions
[19]. Almost all SIV isolates from the Los Alamos Database
contain glutamine at the position corresponding to the 119th or
120th position of the HIV-2 CA in the presence of strong OWM
TRIM5a pressure. After entry of SIVsm into the human
population, which lacks OWM TRIM5a pressure, some viruses
were presumably forced to change glutamine to proline by
mutating the second nucleotide of the codon. This change may
have been driven by specific immune responses against the HIV-2
CA. Similarly, alanine viruses may have evolved from the proline
virus after transmission to individuals lacking such responses by
changing the first nucleotide of the codon in order to become more
resistant to human TRIM5a. Glycine viruses may have further
evolved from the alanine virus by changing the second nucleotide
of the codon. However, it is unclear why serine, histidine,
threonine and leucine viruses have not been identified despite their
nearly normal levels of growth. It is possible that certain human
immune responses prevented their emergence.
In a sharp contrast to CM TRIM5a, Rh TRIM5a could restrict
both CM TRIM5a-sensitive and -resistant HIV-2 strains [8].
SIVmac239 is resistant to Rh TRIM5a, but chimeric SIVmac239
with L4/5 of HIV-2 strains GH123 [25] or ROD [21] were
efficiently restricted by Rh TRIM5a. Therefore, the L4/5 of HIV-
2 CA is also a critical determinant for Rh TRIM5a-mediated
restriction. In the present study, we have shown that CM
TRIM5a-sensitive HIV-2 viruses have a specific structure in the
L4/5 of the CA. However, the 3-D structure of Rh and CM
TRIM5a remains unsolved. To elucidate the more detailed
molecular mechanism of the interaction between TRIM5a and
the CA, structural information about TRIM5a is essential. A
docking study based on such information is likely to shed light on
the antiviral mechanism of TRIM5a.
In summary, we showed that a hydrogen bond between the
97th D and the 119th R of HIV-2 CA affected viral sensitivity to
CM TRIM5a and that both L4/5 and L6/7 are responsible for
CA recognition by CM TRIM5a.
Methods
Cell cultures
293T cells were maintained in Dulbecco’s Modified Eagle
medium, and HeLa cells were maintained in Minimum Essential
Medium. The human T-cell line MT4 was maintained in RPMI
medium. All media were supplemented with 10% fetal bovine
serum and 1% penicillin-streptomycin.
Plasmid construction
Mutant HIV-2 GH123 or SIVmac239 viruses were generated
by site-directed mutagenesis. Infectious viruses were prepared by
transfection of 293T cells with resultant proviral DNA clones. The
viral titer was determined by measuring p25 or p27 with a
RetroTek antigen ELISA kit (ZeptoMetrix, Buffalo, NY).
Construction of recombinant Sendai viruses (SeV) expressing C-
terminally HA-tagged CM TRIM5a (CM-TRIM5a-SeV) and
CM-TRIM5a lacking the PRYSPRY domain (CM-SPRY(–)-SeV)
were described previously [5,20].
Viral infection
MT4 cells (1610
5) were infected with SeV expressing each of
the TRIM5as at a multiplicity of infection of 10 plaque-forming
units per cell and incubated at 37uC for 9 h. Cells were then
superinfected with 20 ng of p25 of HIV-2 GH123 derivatives or
with 40 ng of p27 SIVmac239 derivatives. The culture superna-
tants were collected periodically, and the level of p25 or p27 was
measured with a RetroTek antigen ELISA kit (ZeptoMetrix).
Viral particle purification and western blotting
The culture supernatant of 293T cells transfected with plasmids
encoding HIV-2 GH123 and GH123 mutants were clarified by
low-speed centrifugation. The resultant supernatants (10 ml) were
layered onto a 2 ml cushion of 20% sucrose and centrifuged at
35,000 rpm for 2 h at 4uC in a Beckman SW41 rotor. Pelleted
viral particles were resuspended in PBS. Lysates were normalized
Figure 8. Surface structure of the HIV-2 capsid N-terminal
domain. Surface structure of the GH123 and mutant GH123 CAs
visualized with PyMOL. Red color indicates the 120th amino acid of the
GH123 and mutant GH123 CAs.
doi:10.1371/journal.pone.0022779.g008
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western blotting with the SIV-infected monkey serum.
Molecular modeling and MD simulation
We used MD simulations [26] to analyze structural dynamics of
the HIV-2 CA N-terminal domain. First, initial CA structures for
MD simulation were constructed by homology modeling [27]
using the Molecular Operating Environment, MOE 2008.1002
(Chemical Computing Group Inc., Montreal, Quebec, Canada) as
described [20,28]. We used the high-resolution crystal structure of
the HIV-2 CA N-terminal domain at a resolution of 1.25 A ˚ (PDB
code: 2WLV [29]) as the modeling template. Structural dynamics
of these HIV-2 CA models in water environment were analyzed
using MD simulations with the SANDER module in the AMBER
9 program package [30] and the AMBER99SB force field [31]
with the TIP3P water model. Bond lengths involving hydrogen
were constrained with SHAKE [32] and the time step for all MD
simulations was set to 2 fs. After heating calculations for 20 ps to
310 K using the NVT ensemble, the simulations were executed
using the NPT ensemble at 1 atm and at 310 K for 20 ns.
Hydration analyses were performed using the ptraj module in
AMBER. A maximum cutoff angle of 120.0u and cutoff length of
3.5 A ˚ were used in hydrogen bond definitions. The surface
structure of CA is visualized with PyMOL 1.2r1 (The PyMOL
Molecular Graphics System, http://pymol.sourceforge.net/).
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